BPI
RMD icon

BFC Planning, Inc.’s ResMed RMD Stock Holding History

BFC Planning, Inc.’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Buy
135
+14
+12% +$2.9K ﹤0.01% 1878
2026
Q1 		$27.2K Hold
121
– – ﹤0.01% 1577
2025
Q4 		$29.2K Sell
121
-766
-86% -$196K ﹤0.01% 1581
2025
Q3 		$243K Hold
887
– – 0.02% 608
2025
Q2 		$229K Buy
887
+766
+633% +$183K 0.02% 588
2025
Q1 		$27.1K Sell
121
-642
-84% -$150K ﹤0.01% 1344
2024
Q4 		$175K Buy
+763
New +$184K 0.01% 663

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFC Planning, Inc.'s RMD Position: Q2 2026 in Review

BFC Planning, Inc. increased its ResMed (RMD) stake by 12% in Q2 2026, buying an estimated $2.9K and bringing the position to 135 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

BFC Planning, Inc. first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $243K in Q3 2025. 894 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • BFC Planning, Inc. held 135 shares of ResMed worth $26.4K as of Q2 2026.
  • BFC Planning, Inc. bought 14 ResMed shares in Q2 2026, an estimated $2.9K.
  • ResMed made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #1878 holding.
  • BFC Planning, Inc. first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s ResMed position peaked at $243K in Q3 2025.
  • 894 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.